SCL as reported
Stepan Company reported $2.34B of revenue over the trailing twelve months, +5.5% on the year before. 11 reported series are charted on this page, each one as filed.
$2.34B
Revenue, trailing twelve months · to Q1 2026 · +5.5% against the twelve months before
- Net Income
- −$14M
Net Income · −125% year on year · trailing twelve months to Q1 2026
- Free Cash Flow
- $37M
Free Cash Flow · +1695% year on year · trailing twelve months to Q1 2026
- Op Margin
- 0.10%
Op Margin · trailing twelve months to Q1 2026
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Revenue | $2.34B | +5.5% | Q1 2026 |
| Net Income | −$14M | −125% | Q1 2026 |
| EPS | −$0.62 | −125% | Q1 2026 |
| Gross Margin | 11% | n/a | Q1 2026 |
| Op Margin | 0.10% | n/a | Q1 2026 |
| Net Margin | −0.55% | n/a | Q1 2026 |
| ROE | 2.7% | n/a | Q1 2026 |
| ROA | 1.4% | n/a | Q1 2026 |
| ROIC | 2.6% | n/a | Q1 2026 |
| Free Cash Flow | $37M | +1695% | Q1 2026 |
| P/E | 22.2 | n/a | Q4 2025 |
Every figure straight from the statements as filed with the SEC, no scoring, no adjustment. Open a series for its full history.
Stepan Company (SCL) - Revenue & ProfitRevenue & ProfitStepan Company (SCL)
Revenue (TTM)Net Income (TTM)
Powered byryufin.com
Specialty Chemicals
Ranks #27 of 36 by Smart Score